Your browser doesn't support javascript.
loading
Breast lesions in reduction mammaplasty specimens: a histopathological pattern in 534 patients.
Tadler, M; Vlastos, G; Pelte, M-F; Tille, J-C; Bouchardy, C; Usel, M; Pittet-Cuénod, B; Modarressi, A.
Afiliação
  • Tadler M; Department of Plastic, Reconstructive and Aesthetic Surgery, University Hospitals of Geneva and Faculty of Medicine, Geneva CH-1211, Switzerland.
  • Vlastos G; Senology Unit, University Hospitals of Geneva and Faculty of Medicine, Geneva CH-1211, Switzerland.
  • Pelte MF; Division of Clinical Pathology, University Hospitals of Geneva and Faculty of Medicine, Geneva CH-1206, Switzerland.
  • Tille JC; Division of Clinical Pathology, University Hospitals of Geneva and Faculty of Medicine, Geneva CH-1206, Switzerland.
  • Bouchardy C; Geneva Cancer Registry, Institute for Social and Preventive Medicine, University of Geneva, Geneva CH-1205, Switzerland.
  • Usel M; Geneva Cancer Registry, Institute for Social and Preventive Medicine, University of Geneva, Geneva CH-1205, Switzerland.
  • Pittet-Cuénod B; Department of Plastic, Reconstructive and Aesthetic Surgery, University Hospitals of Geneva and Faculty of Medicine, Geneva CH-1211, Switzerland.
  • Modarressi A; Department of Plastic, Reconstructive and Aesthetic Surgery, University Hospitals of Geneva and Faculty of Medicine, Geneva CH-1211, Switzerland.
Br J Cancer ; 110(3): 788-91, 2014 Feb 04.
Article em En | MEDLINE | ID: mdl-24231955
BACKGROUND: The prevalence of breast lesions (benign, precancerous and cancer lesions) in reduction mammaplasty (RM) specimens has rarely been reported in Europe and never in the Swiss population. METHODS: Personal and histopathological data from 534 female patients who underwent RM were reviewed. RESULTS: Benign and/or malignant lesions were detected in 76.2% of all patients. Benign breast lesions associated with an increased risk of developing breast cancer represented 2.8% of all lesions. Breast cancer in situ was identified in 5 (0.9%) patients. Patient age and previous history of breast cancer were risk factors for incidental breast cancer. CONCLUSION: The rate of incidental carcinoma in situ was higher for patients with breast cancer history. Probably due to preoperative breast cancer investigation, no occult invasive breast cancer was found in reduction mammary specimens. Therefore before RM, breast cancer evaluation should be considered for all patients, especially for those with breast cancer risk factors (e.g., patient age, personal history of breast cancer).
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma in Situ / Mamoplastia Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Suíça País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma in Situ / Mamoplastia Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Suíça País de publicação: Reino Unido